摘要
Drug discovery and development affects various aspects of human health and dramatically impacts the pharmaceutical market. However, investments in a new drug often go unrewarded due to the long and complex process of drug research and development (R&D). With the advancement of experimental technology and computer hardware, artificial intelligence (AI) has recently emerged as a leading tool in analyzing abundant and high-dimensional data. Explosive growth in the size of biomedical data provides advantages in applying AI in all stages of drug R&D. Driven by big data in biomedicine, AI has led to a revolution in drug R&D, due to its ability to discover new drugs more efficiently and at lower cost. This review begins with a brief overview of common AI models in the field of drug discovery; then, it summarizes and discusses in depth their specific applications in various stages of drug R&D, such as target discovery, drug discovery and design, preclinical research, automated drug synthesis, and influences in the pharmaceutical market. Finally, the major limitations of AI in drug R&D are fully discussed and possible solutions are proposed.
学科与关键词
- Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning ApproachesKim, Hyunho; Kim, Eunyoung; Lee, Ingoo; Bae, Bongsung; Park, Minsu; Nam, Hojung*BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2020, 25(6): 895-930.被引 43
- AI in drug development: a multidisciplinary perspectiveGallego, Victor; Naveiro, Roi; Roca, Carlos; Rios Insua, David; Campillo, Nuria E.*MOLECULAR DIVERSITY, 2021, 25(3): 1461-1479.被引 19
- Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive reviewTripathi, Neetu; Goshisht, Manoj Kumar*; Sahu, Sanat Kumar; Arora, CharuMOLECULAR DIVERSITY, 2021, 25(3): 1643-1664.被引 20
